-
[1]
Kai Lin, 2010: Development of Novel Antiviral Therapies for Hepatitis C Virus, Virologica Sinica, 25, 246-266. doi: 10.1007/s12250-010-3140-2
-
[2]
Pinghu Zhang, Shuo Zhai, Jinhong Chang, Ju-Tao Guo, 2018: In Vitro Anti-hepatitis B Virus Activity of 2', 3'-Dideoxyguanosine, Virologica Sinica, 33, 538-544. doi: 10.1007/s12250-018-0065-7
-
[3]
Wanwan Zhang, Xiaoqi Chen, Fangzhao Yu, Fengquan Li, Wangdong Li, Meisheng Yi, Kuntong Jia, 2021: α-Lipoic Acid Exerts Its Antiviral Effect against Viral Hemorrhagic Septicemia Virus (VHSV) by Promoting Upregulation of Antiviral Genes and Suppressing VHSV-Induced Oxidative Stress, Virologica Sinica, 36, 1520-1531. doi: 10.1007/s12250-021-00440-5
-
[4]
Jia Dan, Lin Nie, Xudong Jia, Cuiying Xu, Jing Cai, Yuan Lin, Jun Hu, Wenbo Zhu, Yinyin Li, Dong Chen, Ying Liu, Cheng Hu, Guangmei Yan, Jiankai Liang, Qinfen Zhang, 2021: Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells, Virologica Sinica, 36, 655-666. doi: 10.1007/s12250-020-00339-7
-
[5]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
-
[6]
Jaemoo Kim, Jihyun Yang, Young Bong Kim, Hee-Jung Lee, Sehyun Kim, Haryoung Poo, 2019: Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis, Virologica Sinica, 34, 563-571. doi: 10.1007/s12250-019-00135-y
-
[7]
Junming Shi, Zhengyuan Su, Zhaojun Fan, Jun Wang, Siqing Liu, Bo Zhang, Hongping Wei, Shoukat Jehan, Nadia Jamil, Shu Shen, Fei Deng, 2017: Extensive evolution analysis of the global chikungunya virus strains revealed the origination of CHIKV epidemics in Pakistan in 2016, Virologica Sinica, 32, 520-532. doi: 10.1007/s12250-017-4077-5
-
[8]
Wenxi An, Ningning Ge, Yilin Cao, Jin Sun, Xia Jin, 2017: Recent progress on chikungunya virus research, Virologica Sinica, 32, 441-453. doi: 10.1007/s12250-017-4072-x
-
[9]
Jun Luo, Yue Zhang, Yang Wang, Qing Liu, Jiesen Li, Hongling He, Yongwen Luo, Shile Huang, Xiaofeng Guo, 2021: Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication, Virologica Sinica, 36, 721-729. doi: 10.1007/s12250-021-00349-z
-
[10]
Yang-fei XIANG, Ying PEI, Yi-fei WANG, 2008: Current Status of Natural Products from Plants as Anti-herpes Simplex Virus 1 Agents, Virologica Sinica, 23, 305-314. doi: 10.1007/s12250-008-2962-7
-
[11]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
-
[12]
Si-Qing Liu, Xiao Li, Ya-Nan Zhang, Ai-Li Gao, Cheng-Lin Deng, Jun-Hua Li, Shoukat Jehan, Nadia Jamil, Fei Deng, Hongping Wei, Bo Zhang, 2017: Detection, isolation, and characterization of chikungunya viruses associated with the Pakistan outbreak of 2016–2017, Virologica Sinica, 32, 511-519. doi: 10.1007/s12250-017-4059-7
-
[13]
Yue Wang, Huimin Huang, Dongliang Li, Chenxu Zhao, Shuai Li, Panpan Qin, Yaqin Li, Xia Yang, Wenjuan Du, Wentao Li, Yongtao Li, 2023: Identification of niclosamide as a novel antiviral agent against porcine epidemic diarrhea virus infection by targeting viral internalization, Virologica Sinica, 38, 296-308. doi: 10.1016/j.virs.2023.01.008
-
[14]
Yu-Jia Shi, Jia-Qi Li, Hong-Qing Zhang, Cheng-Lin Deng, Qin-Xuan Zhu, Bo Zhang, Xiao-Dan Li, 2023: A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene, Virologica Sinica, 38, 585-594. doi: 10.1016/j.virs.2023.06.007
-
[15]
Peiqi Yin, Xia Jian, Yihan Liu, Yuwen Liu, Lu Lv, Haoran Cui, Leiliang Zhang, 2023: Elucidating cellular interactome of chikungunya virus identifies host dependency factors, Virologica Sinica, 38, 497-507. doi: 10.1016/j.virs.2023.05.007
-
[16]
Meiyue Dong, Yanyan Wang, Ping Li, Zinuo Chen, Varada Anirudhan, Qinghua Cui, Lijun Rong, Ruikun Du, 2023: Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor, Virologica Sinica, 38, 931-939. doi: 10.1016/j.virs.2023.09.003
-
[17]
Zherui Zhang, Hongqing Zhang, Yanan Zhang, Qiuyan Zhang, Qiaojie Liu, Yanyan Hu, Xiaoling Chen, Jing Wang, Yujia Shi, Chenglin Deng, Peng Gong, Bo Zhang, Xiaodan Li, Bing Zhu, Hanqing Ye, 2023: Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase, Virologica Sinica, 38, 470-479. doi: 10.1016/j.virs.2023.04.008
-
[18]
Jia Dan, Lin Nie, Xudong Jia, Cuiying Xu, Jing Cai, Yuan Lin, Jun Hu, Wenbo Zhu, Yinyin Li, Dong Chen, Ying Liu, Cheng Hu, Guangmei Yan, Jiankai Liang, Qinfen Zhang, 2021: Correction to: Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells, Virologica Sinica, 36, 830-831. doi: 10.1007/s12250-021-00429-0
-
[19]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
-
[20]
Shili Zhou, Quanshi Lin, Changbai Huang, Xiaotong Luo, Xu Tian, Chao Liu, Ping Zhang, 2022: Rottlerin plays an antiviral role at early and late steps of Zika virus infection, Virologica Sinica, 37, 685-694. doi: 10.1016/j.virs.2022.07.012